Escalation To High-Dose ICS Versus Dupilumab Initiation in Uncontrolled Asthma Patients on Medium-Dose ICS: A Matched Analysis of Administrative Claims

Journal of Allergy and Clinical Immunology
February 1, 2026
Cited by 0


Related Papers